Predictors of remission in Cushing’s disease after transsphenoidal endoscopic adenomectomy
DOI: https://doi.org/10.29296/25877305-2019-08-06
Issue:
8
Year:
2019
Two-three-day postoperative examination results, such as a serum cortisol level of ≤388 nmol/l with 94.9% sensitivity and 75.9% specificity and a plasma adrenocorticotropic hormone level of ≤20 pg/ml with 83.3% sensitivity and 95.8% specificity, can be used as the optimal prognostic criteria for remission in Cushing’s disease one year after transsphenoidal endoscopic adenomectomy.
Keywords:
endocrinology
Cushing’s disease
transsphenoidal endoscopic adenomectomy
cortisol
adrenocorticotropic hormone
hypercorticism
remission
References:
- Newell-Price J., Trainer P., Besser G. et al. The diagnosis and differential diagnosis of Cushing’s and pseudo-Cushing’s states // Endocrine Rev. – 2019; 19: 647–72.
- Bertagna X., Guignat L., Groussin L. et al. Cushing’s disease // Best Pract. Res. Clin. Endocrinol. Metab. – 2009; 23: 607–23.
- Arnaldi G., Angeli A., Atkinson A. et al. Diagnosis and complications of Cushing’s syndrome: a consensus statement // J. Clin. Endocrinol. Metab. – 2003; 88 (12): 5593–602.
- Sharma S., Nieman L., Feelders R. Cushing’s syndrome: epidemiology and developments in disease management // Clin. Epidemiol. – 2015; 7: 281–93.
- Invitti C., Pecori Giraldi F., De Martin M. et al. The Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypotalamic-Pituitary-Adrenal Axis Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study // J. Clin. Endocrinol. Metab. – 1999; 84: 440–8.
- Clayton R., Raskauskiene D., Reulen R. et al. Mortality and morbidity in Cushing’s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature // J. Clin. Endocrinol. Metabol. – 2011; 96: 632–42.
- Abellán Galiana P., Fajardo Montañana C., Riesgo Suárez P. et al. Predictors of longterm remission after transsphenoidal surgery in Cushing’s disease // Endocrinol. Nutr. – 2013; 60: 475–82.
- Biller B., Grossman A., Stewart P. et al. Treatment of adrenocorticotropindependent Cushing’s syndrome: a consensus statement // J. Clin. Endocrinol. Metab. – 2008; 93: 2454–62.
- Hameed N., Yedinak C., Brzana J. et al. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing’s disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience // Pituitary. – 2013; 16: 452–8.
- Petersenn S., Beckers A., Ferone D. et al. Outcomes in patients with Cushing’s disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence // Eur. J. Endocrinol. – 2015; 172: 227–39.
- Marova E., Kolesnikova G., Arapova S. et al. Factors predicting the outcomes of removal of corticotropinom in Cushing’s disease // Endocrine Surgery. – 2016; 10 (4): 20–30.
- Lindsay J., Oldfield E., Stratakis C. et al. The postoperative basal cortisol and CRH tests for prediction of longterm remission from Cushing’s disease after transsphenoidal surgery // J. Clin. Endocrinol. Metab. – 2011; 96: 2057–64.
- Ironside N., Chatain G., Asuzu D. et al. Earlier post-operative hypocortisolemia may predict durable remission from Cushing’s disease // Eur. J. Endocrinol. – 2018; 178 (3): 255–63.
- Nadezhdina E., Rebrova O., Ivashenko O. et al. Factors affecting the probability of recurrence of the Cushing’s disease within 3 years after effective neurosurgical treatment // Endocrine Surgery. – 2018; 12 (2): 70–80.
- Esposito F., Dusick J., Cohan P. et al. Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease // J. Clin. Endocrinol. Metab. – 2006; 91: 7–13.
- Pereira A., van Aken M., van Dulken H. et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease // J. Clin. Endocrinol. Metab. – 2003; 88: 5858–64.
- Sostenaro F., Rodrigues T., Rollin G. et al. Evaluation of Cushing’s disease remission after transsphenoidal surgery based on early serum cortisol dynamics // Clin. Endocrinol. – 2014; 80: 411–8.
- Acebes J., Martino J., Masuet C. Early postoperative ACTH and cortisol as predictors of remission in Cushing’s disease // Acta Neurochirurgica. – 2007; 149: 471–7.
- El Asmar N., Rajpal A., Selman W. et al. The Value of Perioperative Levels of ACTH, DHEA, and DHEA-S and Tumor Size in Predicting Recurrence of Cushing Disease // J. Clin. Endocrinol. Metab. – 2018; 103 (2): 477–85.
- Valassi E., Biller B., Swearingen B. et al. Delayed remission after transsphenoidal surgery in patients with Cushing’s disease // J. Clin. Endocrinol. Metab. – 2010; 95 (2): 601–10.
- Alwani R., de Herder W., van Aken M. et al. Biochemical predictors of outcome of pituitary surgery for Cushing’s disease // Neuroendocrinology. – 2010; 91: 169–78.
- Colombo P., Dall’Asta C., Barbetta L. et al. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing’s disease // Eur. J. Endocrinol. – 2000; 143: 227–34.
- Romanholi D., Machado M., Pereira C. et al. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease // Clin. Endocrinol. (Oxf.). – 2008; 69: 117–22.
- Le Marc’hadour P., Muller M., Albarel F. et al. Postoperative follow-up of Cushing’s disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison // Clin. Endocrinol. – 2015; 83: 216–22.